{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,10,9]],"date-time":"2026-10-09T17:49:46Z","timestamp":1791568186262,"version":"4.3.4"},"reference-count":255,"publisher":"Elsevier BV","license":[{"start":{"date-parts":[[2025,2,1]],"date-time":"2025-02-01T00:00:00Z","timestamp":1738368000000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/tdm\/userlicense\/1.0\/"},{"start":{"date-parts":[[2025,2,1]],"date-time":"2025-02-01T00:00:00Z","timestamp":1738368000000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/legal\/tdmrep-license"},{"start":{"date-parts":[[2025,2,1]],"date-time":"2025-02-01T00:00:00Z","timestamp":1738368000000},"content-version":"stm-asf","delay-in-days":0,"URL":"https:\/\/doi.org\/10.15223\/policy-017"},{"start":{"date-parts":[[2025,2,1]],"date-time":"2025-02-01T00:00:00Z","timestamp":1738368000000},"content-version":"stm-asf","delay-in-days":0,"URL":"https:\/\/doi.org\/10.15223\/policy-037"},{"start":{"date-parts":[[2025,2,1]],"date-time":"2025-02-01T00:00:00Z","timestamp":1738368000000},"content-version":"stm-asf","delay-in-days":0,"URL":"https:\/\/doi.org\/10.15223\/policy-012"},{"start":{"date-parts":[[2025,2,1]],"date-time":"2025-02-01T00:00:00Z","timestamp":1738368000000},"content-version":"stm-asf","delay-in-days":0,"URL":"https:\/\/doi.org\/10.15223\/policy-029"},{"start":{"date-parts":[[2025,2,1]],"date-time":"2025-02-01T00:00:00Z","timestamp":1738368000000},"content-version":"stm-asf","delay-in-days":0,"URL":"https:\/\/doi.org\/10.15223\/policy-004"}],"content-domain":{"domain":["elsevier.com","sciencedirect.com"],"crossmark-restriction":true},"short-container-title":["International Immunopharmacology"],"published-print":{"date-parts":[[2025,2]]},"DOI":"10.1016\/j.intimp.2024.113960","type":"journal-article","created":{"date-parts":[[2025,1,1]],"date-time":"2025-01-01T02:12:53Z","timestamp":1735697573000},"page":"113960","update-policy":"https:\/\/doi.org\/10.1016\/elsevier_cm_policy","source":"Crossref","is-referenced-by-count":17,"special_numbering":"C","title":["Clinical implications of human Parvovirus B19 infection on autoimmunity and autoimmune diseases"],"prefix":"10.1016","volume":"147","author":[{"given":"Chih-Chen","family":"Tzang","sequence":"first","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Liang-Yun","family":"Chi","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Chen-Yu","family":"Lee","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Zi-Yi","family":"Chang","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Chiao-An","family":"Luo","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Yan-Hua","family":"Chen","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Tzu-An","family":"Lin","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Liang-Chien","family":"Yu","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Yo-Rong","family":"Chen","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Bor-Show","family":"Tzang","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"ORCID":"https:\/\/orcid.org\/0000-0003-0400-1249","authenticated-orcid":false,"given":"Tsai-Ching","family":"Hsu","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"78","reference":[{"key":"10.1016\/j.intimp.2024.113960_b0005","doi-asserted-by":"crossref","DOI":"10.1155\/2022\/1639990","article-title":"The Pathogenic Aspects of Human Parvovirus B19 NS1 Protein in Chronic and Inflammatory Diseases","volume":"2022","author":"Jalali","year":"2022","journal-title":"Interdiscip Perspect Infect Dis."},{"key":"10.1016\/j.intimp.2024.113960_b0010","doi-asserted-by":"crossref","DOI":"10.1111\/tid.14028","article-title":"Parvovirus B19 infection in pediatric allogeneic hematopoietic cell transplantation - Single-center experience and review","volume":"25","author":"Holterhus","year":"2023","journal-title":"Transpl Infect Dis."},{"key":"10.1016\/j.intimp.2024.113960_b0015","doi-asserted-by":"crossref","first-page":"279","DOI":"10.1136\/jclinpath-2015-203455","article-title":"The role of parvovirus B19 in the pathogenesis of autoimmunity and autoimmune disease","volume":"69","author":"Kerr","year":"2016","journal-title":"J Clin Pathol."},{"key":"10.1016\/j.intimp.2024.113960_b0020","doi-asserted-by":"crossref","first-page":"206","DOI":"10.1111\/j.1423-0410.1995.tb02595.x","article-title":"Human Parvovirus B19 Infection in Blood-Donors","volume":"69","author":"Tsujimura","year":"1995","journal-title":"Vox Sang."},{"key":"10.1016\/j.intimp.2024.113960_b0025","doi-asserted-by":"crossref","first-page":"151","DOI":"10.1099\/00222615-25-2-151","article-title":"The prevalence of antibody to human parvovirus B19 in England and Wales","volume":"25","author":"Cohen","year":"1988","journal-title":"J Med Microbiol."},{"key":"10.1016\/j.intimp.2024.113960_b0030","doi-asserted-by":"crossref","first-page":"449","DOI":"10.1017\/S0950268899003817","article-title":"The age-specific prevalence of human parvovirus immunity in Victoria, Australia compared with other parts of the world","volume":"124","author":"Kelly","year":"2000","journal-title":"Epidemiol Infect."},{"key":"10.1016\/j.intimp.2024.113960_b0035","first-page":"83","article-title":"Human parvovirus B19 infections in women of childbearing age and within families","volume":"8","author":"Koch","year":"1989","journal-title":"Pediatr Infect Dis J."},{"key":"10.1016\/j.intimp.2024.113960_b0040","doi-asserted-by":"crossref","first-page":"485","DOI":"10.1128\/CMR.15.3.485-505.2002","article-title":"Human parvovirus B19","volume":"15","author":"Heegaard","year":"2002","journal-title":"Clin Microbiol Rev."},{"key":"10.1016\/j.intimp.2024.113960_b0045","doi-asserted-by":"crossref","first-page":"444","DOI":"10.1016\/j.virol.2008.01.002","article-title":"VP1u phospholipase activity is critical for infectivity of full-length parvovirus B19 genomic clones","volume":"374","author":"Filippone","year":"2008","journal-title":"Virology"},{"key":"10.1016\/j.intimp.2024.113960_b0050","doi-asserted-by":"crossref","first-page":"46","DOI":"10.1002\/pd.1619","article-title":"Parvovirus B19 infection in pregnancy: maternal and fetal viral load measurements related to clinical parameters","volume":"27","author":"de Haan","year":"2007","journal-title":"Prenat Diagn."},{"key":"10.1016\/j.intimp.2024.113960_b0055","series-title":"Viruses and the Lung: Infections and Non-Infectious Viral-Linked Lung Disorders","first-page":"133","article-title":"Parvovirus","author":"Green","year":"2014"},{"key":"10.1016\/j.intimp.2024.113960_b0060","doi-asserted-by":"crossref","first-page":"540","DOI":"10.3390\/v13040540","article-title":"Prevalence and Phylogenetic Analysis of Parvovirus (B19V) among Blood Donors with Different Nationalities Residing in Qatar","volume":"13","author":"Abdelrahman","year":"2021","journal-title":"Viruses"},{"key":"10.1016\/j.intimp.2024.113960_b0065","doi-asserted-by":"crossref","first-page":"R82","DOI":"10.1186\/ar2281","article-title":"Seroprevalence of parvovirus B19 IgG in children affected by juvenile idiopathic arthritis","volume":"9","author":"Weissbrich","year":"2007","journal-title":"Arthritis Res Ther."},{"key":"10.1016\/j.intimp.2024.113960_b0070","doi-asserted-by":"crossref","first-page":"1708","DOI":"10.3390\/microorganisms12081708","article-title":"Parvovirus B19 in Rheumatic Diseases","volume":"12","author":"Arvia","year":"2024","journal-title":"Microorganisms."},{"key":"10.1016\/j.intimp.2024.113960_b0075","doi-asserted-by":"crossref","first-page":"17331","DOI":"10.3390\/ijms160817331","article-title":"Infections and Systemic Lupus Erythematosus: Binding or Sparring Partners?","volume":"16","author":"Rigante","year":"2015","journal-title":"Int J Mol Sci."},{"key":"10.1016\/j.intimp.2024.113960_b0080","doi-asserted-by":"crossref","first-page":"2110","DOI":"10.1056\/NEJMra1100359","article-title":"Systemic Lupus Erythematosus","volume":"365","author":"Tsokos","year":"2011","journal-title":"N. Engl. J. Med."},{"key":"10.1016\/j.intimp.2024.113960_b0085","doi-asserted-by":"crossref","first-page":"605","DOI":"10.1038\/nrrheum.2016.137","article-title":"The global burden of SLE: prevalence, health disparities and socioeconomic impact","volume":"12","author":"Carter","year":"2016","journal-title":"Nat. Rev. Rheumatol."},{"key":"10.1016\/j.intimp.2024.113960_b0090","doi-asserted-by":"crossref","first-page":"2100","DOI":"10.1002\/art.11105","article-title":"Sex hormones and systemic lupus erythematosus: Review and meta-analysis","volume":"48","author":"McMurray","year":"2003","journal-title":"Arthritis Rheum."},{"key":"10.1016\/j.intimp.2024.113960_b0095","series-title":"Systemic Lupus Erythematosus","first-page":"673","article-title":"Chapter 36 - Epidemiology of Systemic Lupus Erythematosus","author":"Duarte","year":"2011"},{"key":"10.1016\/j.intimp.2024.113960_b0100","doi-asserted-by":"crossref","first-page":"218","DOI":"10.1016\/S1568-9972(03)00014-4","article-title":"Parvovirus B19 infection and autoimmune disease","volume":"2","author":"Lehmann","year":"2003","journal-title":"Autoimmun Rev."},{"key":"10.1016\/j.intimp.2024.113960_b0105","first-page":"169","article-title":"Lupus-like presentation of human parvovirus B19 infection","volume":"19","author":"Kalish","year":"1992","journal-title":"J Rheumatol."},{"key":"10.1016\/j.intimp.2024.113960_b0110","doi-asserted-by":"crossref","first-page":"297","DOI":"10.1016\/S0049-0172(95)80001-8","article-title":"Parvovirus infection mimicking systemic lupus erythematosus","volume":"24","author":"Nesher","year":"1995","journal-title":"Semin Arthritis Rheum."},{"key":"10.1016\/j.intimp.2024.113960_b0115","first-page":"581","article-title":"Ueda R","volume":"37","author":"Banno","year":"1997","journal-title":"Ryumachi"},{"key":"10.1016\/j.intimp.2024.113960_b0120","doi-asserted-by":"crossref","first-page":"314","DOI":"10.1016\/S0049-0172(99)80015-8","article-title":"Parvovirus infection mimicking systemic lupus erythematosus in a pediatric population","volume":"28","author":"Moore","year":"1999","journal-title":"Semin Arthritis Rheum."},{"key":"10.1016\/j.intimp.2024.113960_b0125","doi-asserted-by":"crossref","first-page":"319","DOI":"10.1016\/S0049-0172(99)80016-X","article-title":"Human parvovirus B19 infection: its relationship with systemic lupus erythematosus","volume":"28","author":"Trapani","year":"1999","journal-title":"Semin Arthritis Rheum."},{"key":"10.1016\/j.intimp.2024.113960_b0130","first-page":"2335","article-title":"Antibodies to beta 2-glycoprotein I and cardiolipin with symptoms suggestive of systemic lupus erythematosus in parvovirus B19 infection","volume":"28","author":"Kalt","year":"2001","journal-title":"J Rheumatol."},{"key":"10.1016\/j.intimp.2024.113960_b0135","doi-asserted-by":"crossref","first-page":"573","DOI":"10.1016\/S0002-9343(01)00904-4","article-title":"Lupus-like presentation of parvovirus B19 infection","volume":"111","author":"Narv\u00e1ez Garcia","year":"2001","journal-title":"Am J Med."},{"key":"10.1016\/j.intimp.2024.113960_b0140","first-page":"125","article-title":"Human parvovirus B19 infection mimicking systemic lupus erythematosus in an adult patient","volume":"16","author":"Negro","year":"2001","journal-title":"Ann Ital Med Int."},{"key":"10.1016\/j.intimp.2024.113960_b0145","doi-asserted-by":"crossref","first-page":"662","DOI":"10.1136\/ard.61.7.662","article-title":"Self limiting lupus-like symptoms in patients with parvovirus B19 infection","volume":"61","author":"T\u00f3v\u00e1ri","year":"2002","journal-title":"Ann Rheum Dis."},{"key":"10.1016\/j.intimp.2024.113960_b0150","doi-asserted-by":"crossref","first-page":"642","DOI":"10.1016\/j.semarthrit.2004.07.008","article-title":"Lupus-like presentation of parvovirus B19 infection","volume":"34","author":"S\u00e8ve","year":"2005","journal-title":"Semin Arthritis Rheum."},{"key":"10.1016\/j.intimp.2024.113960_b0155","doi-asserted-by":"crossref","first-page":"119","DOI":"10.1007\/s10067-007-0691-1","article-title":"Emerging lupus-like manifestations in acute parvovirus B19 infection","volume":"27","author":"Sugimoto","year":"2008","journal-title":"Clin Rheumatol."},{"key":"10.1016\/j.intimp.2024.113960_b0160","doi-asserted-by":"crossref","first-page":"411","DOI":"10.1111\/j.1442-200X.2009.02829.x","article-title":"Self-limited lupus-like presentation of human parvovirus B19 infection in a 1-year-old girl","volume":"51","author":"Watanabe","year":"2009","journal-title":"Pediatr Int."},{"key":"10.1016\/j.intimp.2024.113960_b0165","doi-asserted-by":"crossref","first-page":"79","DOI":"10.3109\/03009742.2011.617315","article-title":"Severe glomerulonephritis and encephalopathy associated with parvovirus B19 infection mimicking systemic lupus erythematosus","volume":"41","author":"Cugler","year":"2012","journal-title":"Scand J Rheumatol."},{"key":"10.1016\/j.intimp.2024.113960_b0170","doi-asserted-by":"crossref","first-page":"1342","DOI":"10.1503\/cmaj.121565","article-title":"Parvovirus infection mimicking systemic lupus erythematosus","volume":"185","author":"Cooray","year":"2013","journal-title":"CMAJ"},{"key":"10.1016\/j.intimp.2024.113960_b0175","doi-asserted-by":"crossref","first-page":"182","DOI":"10.1080\/24725625.2020.1832754","article-title":"Refractory liver dysfunction was remarkably improved with chelating agents of Wilson's disease, in a patient with systemic lupus erythematosus-like syndrome after a parvovirus B19 infection","volume":"5","author":"Nameki","year":"2021","journal-title":"Mod Rheumatol Case Rep."},{"key":"10.1016\/j.intimp.2024.113960_b0180","first-page":"1180","article-title":"Human parvovirus infection: rheumatic manifestations, angioedema, C1 esterase inhibitor deficiency, ANA positivity, and possible onset of systemic lupus erythematosus","volume":"23","author":"Fawaz-Estrup","year":"1996","journal-title":"J Rheumatol."},{"key":"10.1016\/j.intimp.2024.113960_b0185","doi-asserted-by":"crossref","first-page":"708","DOI":"10.2169\/internalmedicine.37.708","article-title":"Human parvovirus B19 infection resembling systemic lupus erythematosus","volume":"37","author":"Tanaka","year":"1998","journal-title":"Intern Med."},{"key":"10.1016\/j.intimp.2024.113960_b0190","doi-asserted-by":"crossref","first-page":"505","DOI":"10.1034\/j.1600-0560.2000.027010505.x","article-title":"A causal role for parvovirus B19 infection in adult dermatomyositis and other autoimmune syndromes","volume":"27","author":"Crowson","year":"2000","journal-title":"J Cutan Pathol."},{"key":"10.1016\/j.intimp.2024.113960_b0195","first-page":"763","article-title":"Human parvovirus B19 infection in children: uncommon clinical presentations","volume":"4","author":"Barash","year":"2002","journal-title":"Isr Med Assoc J."},{"key":"10.1016\/j.intimp.2024.113960_b0200","doi-asserted-by":"crossref","first-page":"2430","DOI":"10.3899\/jrheum.100345","article-title":"Parvovirus B19-associated systemic lupus erythematosus: clinical mimicry or autoimmune induction?","volume":"37","author":"Hession","year":"2010","journal-title":"J Rheumatol."},{"key":"10.1016\/j.intimp.2024.113960_b0205","doi-asserted-by":"crossref","first-page":"192","DOI":"10.1159\/000068885","article-title":"Two-year follow-up study after human parvovirus B19 infection","volume":"206","author":"Seishima","year":"2003","journal-title":"Dermatology"},{"key":"10.1016\/j.intimp.2024.113960_b0210","doi-asserted-by":"crossref","first-page":"37","DOI":"10.1177\/096120339100100107","article-title":"Parvovirus B19 infection can induce histiocytic necrotizing lymphadenitis (Kikuchi's disease) associated with systemic lupus erythematosus","volume":"1","author":"Meyer","year":"1991","journal-title":"Lupus"},{"key":"10.1016\/j.intimp.2024.113960_b0215","doi-asserted-by":"crossref","first-page":"158","DOI":"10.1093\/rheumatology\/32.2.158","article-title":"Exacerbation of systemic lupus erythematosus during human parvovirus B19 infection","volume":"32","author":"Chassagne","year":"1993","journal-title":"Br J Rheumatol."},{"key":"10.1016\/j.intimp.2024.113960_b0220","doi-asserted-by":"crossref","first-page":"73","DOI":"10.1016\/S1386-6532(99)00038-4","article-title":"Acute parvovirus B19 infection in connection with a flare of systemic lupus erythematodes in a female patient","volume":"14","author":"Hemauer","year":"1999","journal-title":"J Clin Virol."},{"key":"10.1016\/j.intimp.2024.113960_b0225","doi-asserted-by":"crossref","first-page":"859","DOI":"10.1055\/s-2007-1024432","article-title":"Lang B","volume":"124","author":"Langgartner","year":"1999","journal-title":"Dtsch Med Wochenschr"},{"key":"10.1016\/j.intimp.2024.113960_b0230","doi-asserted-by":"crossref","first-page":"538","DOI":"10.2169\/internalmedicine.42.538","article-title":"Human parvovirus B19 infection during the inactive stage of systemic lupus erythematosus","volume":"42","author":"Suzuki","year":"2003","journal-title":"Intern Med."},{"key":"10.1016\/j.intimp.2024.113960_b0235","doi-asserted-by":"crossref","first-page":"S111","DOI":"10.1016\/j.jaad.2006.11.024","article-title":"Hemophagocytic syndrome presenting with a facial erythema in a patient with systemic lupus erythematosus","volume":"57","author":"Sakai","year":"2007","journal-title":"J Am Acad Dermatol."},{"key":"10.1016\/j.intimp.2024.113960_b0240","first-page":"1165","article-title":"Chronic modulation of the autoimmune response following parvovirus B19 infection","volume":"21","author":"Vigeant","year":"1994","journal-title":"J Rheumatol."},{"key":"10.1016\/j.intimp.2024.113960_b0245","first-page":"849","article-title":"Lupus syndrome after parvovirus B19 infection","volume":"64","author":"Roblot","year":"1997","journal-title":"Rev Rhum Engl Ed."},{"key":"10.1016\/j.intimp.2024.113960_b0250","first-page":"968","article-title":"Postpartum lupus erythematosus associated with parvovirus B19 infection","volume":"24","author":"Nigro","year":"1997","journal-title":"J Rheumatol."},{"key":"10.1016\/j.intimp.2024.113960_b0255","doi-asserted-by":"crossref","first-page":"115","DOI":"10.1046\/j.1198-743x.2001.00361.x","article-title":"Systemic lupus erythematosus associated with acute parvovirus B19 infection","volume":"8","author":"D\u00edaz","year":"2002","journal-title":"Clin Microbiol Infect."},{"key":"10.1016\/j.intimp.2024.113960_b0260","doi-asserted-by":"crossref","first-page":"311","DOI":"10.1097\/MD.0b013e31818ec711","article-title":"Acute viral infections in patients with systemic lupus erythematosus: description of 23 cases and review of the literature","volume":"87","author":"Ramos-Casals","year":"2008","journal-title":"Medicine (Baltimore)"},{"key":"10.1016\/j.intimp.2024.113960_b0265","doi-asserted-by":"crossref","first-page":"936","DOI":"10.1002\/(SICI)1521-4141(199803)28:03<936::AID-IMMU936>3.0.CO;2-X","article-title":"Chronic parvovirus B19 infection induces the production of anti-virus antibodies with autoantigen binding properties","volume":"28","author":"Lunardi","year":"1998","journal-title":"Eur J Immunol."},{"key":"10.1016\/j.intimp.2024.113960_b0270","doi-asserted-by":"crossref","first-page":"103","DOI":"10.1002\/art.1780400115","article-title":"Similarities of specificity and cofactor dependence in serum antiphospholipid antibodies from patients with human parvovirus B19 infection and from those with systemic lupus erythematosus","volume":"40","author":"Loizou","year":"1997","journal-title":"Arthritis Rheum."},{"key":"10.1016\/j.intimp.2024.113960_b0275","doi-asserted-by":"crossref","first-page":"49","DOI":"10.3109\/08860229909066969","article-title":"Catastrophic antiphospholipid syndromes in systemic lupus erythematosus","volume":"21","author":"Stratta","year":"1999","journal-title":"Ren Fail."},{"key":"10.1016\/j.intimp.2024.113960_b0280","doi-asserted-by":"crossref","first-page":"1939","DOI":"10.1002\/art.11038","article-title":"Antiphospholipid antibodies in pediatric and adult patients with rheumatic disease are associated with parvovirus B19 infection","volume":"48","author":"Von Landenberg","year":"2003","journal-title":"Arthritis Rheum."},{"key":"10.1016\/j.intimp.2024.113960_b0285","doi-asserted-by":"crossref","first-page":"447","DOI":"10.1007\/s12026-017-8896-0","article-title":"Does parvovirus infection have a role in systemic lupus erythematosus?","volume":"65","author":"Hod","year":"2017","journal-title":"Immunol Res."},{"key":"10.1016\/j.intimp.2024.113960_b0290","article-title":"Th17-related cytokines in systemic lupus erythematosus patients with dilated cardiomyopathies: a possible linkage to parvovirus B19 infection","volume":"9","author":"Chen","year":"2014","journal-title":"PLoS One"},{"key":"10.1016\/j.intimp.2024.113960_b0295","doi-asserted-by":"crossref","first-page":"239","DOI":"10.1186\/s12967-017-1345-y","article-title":"Cytokine and autoantibody clusters interaction in systemic lupus erythematosus","volume":"15","author":"Pacheco","year":"2017","journal-title":"J Transl Med."},{"key":"10.1016\/j.intimp.2024.113960_b0300","doi-asserted-by":"crossref","first-page":"855","DOI":"10.1016\/j.cca.2012.01.027","article-title":"Significant association of past parvovirus B19 infection with cytopenia in both adult-onset Still's disease and systemic lupus erythematosus patients","volume":"413","author":"Chen","year":"2012","journal-title":"Clin Chim Acta."},{"key":"10.1016\/j.intimp.2024.113960_b0305","doi-asserted-by":"crossref","first-page":"64","DOI":"10.1136\/ard.59.1.64","article-title":"No serological indications that systemic lupus erythematosus is linked with exposure to human parvovirus B19","volume":"59","author":"Bengtsson","year":"2000","journal-title":"Ann Rheum Dis."},{"key":"10.1016\/j.intimp.2024.113960_b0310","doi-asserted-by":"crossref","first-page":"152","DOI":"10.1093\/rheumatology\/40.2.152","article-title":"Human parvovirus B19 infection in patients with systemic lupus erythematosus","volume":"40","author":"Hsu","year":"2001","journal-title":"Rheumatology (Oxford)"},{"key":"10.1016\/j.intimp.2024.113960_b0315","doi-asserted-by":"crossref","first-page":"1286","DOI":"10.1177\/0961203313493032","article-title":"Infection risk in systemic lupus erythematosus patients: susceptibility factors and preventive strategies","volume":"22","author":"Danza","year":"2013","journal-title":"Lupus"},{"key":"10.1016\/j.intimp.2024.113960_b0320","doi-asserted-by":"crossref","first-page":"39","DOI":"10.1136\/annrheumdis-2019-215882","article-title":"2019 update of EULAR recommendations for vaccination in adult patients with autoimmune inflammatory rheumatic diseases","volume":"79","author":"Furer","year":"2020","journal-title":"Ann Rheum Dis."},{"key":"10.1016\/j.intimp.2024.113960_b0325","doi-asserted-by":"crossref","first-page":"742","DOI":"10.1136\/ard-2022-223335","article-title":"2022 EULAR recommendations for screening and prophylaxis of chronic and opportunistic infections in adults with autoimmune inflammatory rheumatic diseases","volume":"82","author":"Fragoulis","year":"2023","journal-title":"Ann Rheum Dis."},{"key":"10.1016\/j.intimp.2024.113960_b0330","doi-asserted-by":"crossref","first-page":"15","DOI":"10.1136\/ard-2023-224762","article-title":"EULAR recommendations for the management of systemic lupus erythematosus: 2023 update","volume":"83","author":"Fanouriakis","year":"2024","journal-title":"Ann Rheum Dis."},{"key":"10.1016\/j.intimp.2024.113960_b0335","doi-asserted-by":"crossref","first-page":"2023","DOI":"10.1016\/S0140-6736(16)30173-8","article-title":"Rheumatoid arthritis","volume":"388","author":"Smolen","year":"2016","journal-title":"Lancet"},{"key":"10.1016\/j.intimp.2024.113960_b0340","doi-asserted-by":"crossref","first-page":"1291","DOI":"10.3390\/jcm12041291","article-title":"The Burden of Rheumatoid Arthritis: Findings from the 2019 Global Burden of Diseases Study and Forecasts for 2030 by Bayesian Age-Period-Cohort Analysis","volume":"12","author":"Cai","year":"2023","journal-title":"J Clin Med."},{"key":"10.1016\/j.intimp.2024.113960_b0345","doi-asserted-by":"crossref","first-page":"771","DOI":"10.1136\/annrheumdis-2019-216243","article-title":"Economic burden of rheumatoid arthritis: a systematic review of literature in biologic era","volume":"79","author":"Hsieh","year":"2020","journal-title":"Ann Rheum Dis."},{"key":"10.1016\/j.intimp.2024.113960_b0350","doi-asserted-by":"crossref","first-page":"123","DOI":"10.1016\/0167-5699(89)90245-4","article-title":"The mosaic of autoimmunity","volume":"10","author":"Shoenfeld","year":"1989","journal-title":"Immunol Today."},{"key":"10.1016\/j.intimp.2024.113960_b0355","doi-asserted-by":"crossref","first-page":"587","DOI":"10.1016\/j.semarthrit.2018.03.011","article-title":"A systematic review of viral exposures as a risk for rheumatoid arthritis","volume":"48","author":"Kudaeva","year":"2019","journal-title":"Semin Arthritis Rheum."},{"key":"10.1016\/j.intimp.2024.113960_b0360","doi-asserted-by":"crossref","first-page":"8227","DOI":"10.1073\/pnas.95.14.8227","article-title":"Human parvovirus B19 as a causative agent for rheumatoid arthritis","volume":"95","author":"Takahashi","year":"1998","journal-title":"PNAS"},{"key":"10.1016\/j.intimp.2024.113960_b0365","doi-asserted-by":"crossref","first-page":"1582","DOI":"10.1002\/1529-0131(200107)44:7<1582::AID-ART281>3.0.CO;2-E","article-title":"Induction of an invasive phenotype by human parvovirus B19 in normal human synovial fibroblasts","volume":"44","author":"Ray","year":"2001","journal-title":"Arthritis & Rheumatism: Official Journal of the American College of Rheumatology."},{"key":"10.1016\/j.intimp.2024.113960_b0370","doi-asserted-by":"crossref","first-page":"4675","DOI":"10.4049\/jimmunol.173.7.4675","article-title":"Human parvovirus B19 transgenic mice become susceptible to polyarthritis","volume":"173","author":"Takasawa","year":"2004","journal-title":"J. Immunol."},{"key":"10.1016\/j.intimp.2024.113960_b0375","doi-asserted-by":"crossref","first-page":"1063","DOI":"10.1016\/S0140-6736(96)09110-6","article-title":"Persistence of parvovirus B19 DNA in synovial membranes of young patients with and without chronic arthropathy","volume":"349","author":"S\u00f6derlund","year":"1997","journal-title":"Lancet"},{"key":"10.1016\/j.intimp.2024.113960_b0380","doi-asserted-by":"crossref","first-page":"832","DOI":"10.1136\/ard.45.10.832","article-title":"Human parvovirus infection in early rheumatoid and inflammatory arthritis","volume":"45","author":"Cohen","year":"1986","journal-title":"Ann Rheum Dis."},{"key":"10.1016\/j.intimp.2024.113960_b0385","doi-asserted-by":"crossref","first-page":"375","DOI":"10.1136\/ard.57.6.375","article-title":"Low frequency of recent parvovirus infection in a population-based cohort of patients with early inflammatory polyarthritis","volume":"57","author":"Harrison","year":"1998","journal-title":"Ann Rheum Dis."},{"key":"10.1016\/j.intimp.2024.113960_b0390","doi-asserted-by":"crossref","first-page":"809","DOI":"10.1093\/rheumatology\/34.9.809","article-title":"A study of the role of parvovirus B19 in rheumatoid arthritis","volume":"34","author":"Kerr","year":"1995","journal-title":"Br J Rheumatol."},{"key":"10.1016\/j.intimp.2024.113960_b0395","doi-asserted-by":"crossref","first-page":"672","DOI":"10.1136\/ard.59.9.672","article-title":"Pathogenesis of human parvovirus B19 in rheumatic disease","volume":"59","author":"Kerr","year":"2000","journal-title":"Ann Rheum Dis."},{"key":"10.1016\/j.intimp.2024.113960_b0400","doi-asserted-by":"crossref","first-page":"129","DOI":"10.7861\/clinmedicine.16-2-129","article-title":"Viral arthritis","volume":"16","author":"Marks","year":"2016","journal-title":"Clin Med (lond)."},{"key":"10.1016\/j.intimp.2024.113960_b0405","doi-asserted-by":"crossref","first-page":"1026","DOI":"10.1016\/S0140-6736(98)12312-7","article-title":"Parvovirus B19 and the pathogenesis of rheumatoid arthritis: a case for historical reasoning","volume":"354","author":"Altschuler","year":"1999","journal-title":"Lancet"},{"key":"10.1016\/j.intimp.2024.113960_b0410","doi-asserted-by":"crossref","first-page":"69","DOI":"10.1016\/j.jcv.2015.09.007","article-title":"Human parvovirus B19 and autoimmune diseases. Review of the literature and pathophysiological hypotheses","volume":"72","author":"Page","year":"2015","journal-title":"J Clin Virol."},{"key":"10.1016\/j.intimp.2024.113960_b0415","doi-asserted-by":"crossref","first-page":"130","DOI":"10.1136\/ard.58.2.130","article-title":"Rheumatoid arthritis after human parvovirus B19 infection","volume":"58","author":"Murai","year":"1999","journal-title":"Ann Rheum Dis."},{"key":"10.1016\/j.intimp.2024.113960_b0420","doi-asserted-by":"crossref","first-page":"419","DOI":"10.1016\/S0140-6736(85)91145-6","article-title":"Human parvovirus arthropathy","volume":"1","author":"White","year":"1985","journal-title":"Lancet"},{"key":"10.1016\/j.intimp.2024.113960_b0425","doi-asserted-by":"crossref","first-page":"281","DOI":"10.1007\/s100670070046","article-title":"High incidence of parvovirus B19 DNA in synovial tissue of patients with undifferentiated mono- and oligoarthritis","volume":"19","author":"Stahl","year":"2000","journal-title":"Clin Rheumatol."},{"key":"10.1016\/j.intimp.2024.113960_b0430","series-title":"The Immunoassay Handbook (fourth Edition)","first-page":"869","article-title":"Chapter 9.15 - Autoimmune Disease","author":"Keren","year":"2013"},{"key":"10.1016\/j.intimp.2024.113960_b0435","doi-asserted-by":"crossref","first-page":"468","DOI":"10.1016\/j.autrev.2005.04.018","article-title":"Anti-citrullinated protein\/peptide antibodies (ACPA) in rheumatoid arthritis: Specificity and relation with rheumatoid factor","volume":"4","author":"Vander Cruyssen","year":"2005","journal-title":"Autoimmun. Rev."},{"key":"10.1016\/j.intimp.2024.113960_b0440","doi-asserted-by":"crossref","first-page":"2569","DOI":"10.1002\/art.27584","article-title":"2010 Rheumatoid arthritis classification criteria: an American College of Rheumatology\/European League Against Rheumatism collaborative initiative","volume":"62","author":"Aletaha","year":"2010","journal-title":"Arthritis Rheum."},{"key":"10.1016\/j.intimp.2024.113960_b0445","doi-asserted-by":"crossref","first-page":"155","DOI":"10.1002\/1529-0131(200001)43:1<155::AID-ANR20>3.0.CO;2-3","article-title":"The diagnostic properties of rheumatoid arthritis antibodies recognizing a cyclic citrullinated peptide","volume":"43","author":"Schellekens","year":"2000","journal-title":"Arthritis Rheum."},{"key":"10.1016\/j.intimp.2024.113960_b0450","doi-asserted-by":"crossref","first-page":"273","DOI":"10.1172\/JCI1316","article-title":"Citrulline is an essential constituent of antigenic determinants recognized by rheumatoid arthritis-specific autoantibodies","volume":"101","author":"Schellekens","year":"1998","journal-title":"J Clin Invest."},{"key":"10.1016\/j.intimp.2024.113960_b0455","doi-asserted-by":"crossref","first-page":"1257","DOI":"10.4103\/jfmpc.jfmpc_25_19","article-title":"Acute parvovirus B19 infection presenting as rheumatoid arthritis mimic","volume":"8","author":"Alexander","year":"2019","journal-title":"J Family Med Prim Care."},{"key":"10.1016\/j.intimp.2024.113960_b0460","doi-asserted-by":"crossref","first-page":"480","DOI":"10.1016\/S0140-6736(94)92725-1","article-title":"Parvovirus B19 and erosive polyarthritis","volume":"343","author":"Tyndall","year":"1994","journal-title":"Lancet"},{"key":"10.1016\/j.intimp.2024.113960_b0465","doi-asserted-by":"crossref","first-page":"422","DOI":"10.1016\/S0140-6736(85)91146-8","article-title":"Human parvovirus-associated arthritis: a clinical and laboratory description","volume":"325","author":"Reid","year":"1985","journal-title":"Lancet"},{"key":"10.1016\/j.intimp.2024.113960_b0470","doi-asserted-by":"crossref","first-page":"3302","DOI":"10.1099\/jgv.0.000621","article-title":"Frequency and significance of parvovirus B19 infection in patients with rheumatoid arthritis","volume":"97","author":"Naciute","year":"2016","journal-title":"J Gen Virol."},{"key":"10.1016\/j.intimp.2024.113960_b0475","doi-asserted-by":"crossref","first-page":"147","DOI":"10.1007\/BF00274934","article-title":"Persistence of B19 parvovirus in synovial membranes of patients with rheumatoid arthritis","volume":"12","author":"Saal","year":"1992","journal-title":"Rheumatol Int."},{"key":"10.1016\/j.intimp.2024.113960_b0480","doi-asserted-by":"crossref","first-page":"41","DOI":"10.1016\/j.cyto.2017.03.002","article-title":"Parvovirus B19 infection modulates the levels of cytokines in the plasma of rheumatoid arthritis patients","volume":"96","author":"Naciute","year":"2017","journal-title":"Cytokine"},{"key":"10.1016\/j.intimp.2024.113960_b0485","doi-asserted-by":"crossref","first-page":"318","DOI":"10.1111\/j.1399-0039.1986.tb00502.x","article-title":"HLA and acute arthritis following human parvovirus infection","volume":"28","author":"Klouda","year":"1986","journal-title":"Tissue Antigens"},{"key":"10.1016\/j.intimp.2024.113960_b0490","doi-asserted-by":"crossref","first-page":"63","DOI":"10.1136\/ard.55.1.63","article-title":"Effect of HLA type and hypocomplementaemia on the expression of parvovirus arthritis: one year follow up of an outbreak","volume":"55","author":"Gendi","year":"1996","journal-title":"Ann Rheum Dis."},{"key":"10.1016\/j.intimp.2024.113960_b0495","first-page":"887","article-title":"Parvovirus B19 infection in patients with rheumatoid arthritis in Taiwan","volume":"33","author":"Chen","year":"2006","journal-title":"J Rheumatol."},{"key":"10.1016\/j.intimp.2024.113960_b0500","doi-asserted-by":"crossref","first-page":"447","DOI":"10.1086\/341947","article-title":"Association of symptomatic acute human parvovirus B19 infection with human leukocyte antigen class I and II alleles","volume":"186","author":"Kerr","year":"2002","journal-title":"J Infect Dis."},{"key":"10.1016\/j.intimp.2024.113960_b0505","first-page":"1520","article-title":"Worldwide prevalence of juvenile arthritis why does it vary so much?","volume":"29","author":"Manners","year":"2002","journal-title":"J Rheumatol."},{"key":"10.1016\/j.intimp.2024.113960_b0510","doi-asserted-by":"crossref","first-page":"767","DOI":"10.1016\/S0140-6736(07)60363-8","article-title":"Juvenile idiopathic arthritis","volume":"369","author":"Ravelli","year":"2007","journal-title":"Lancet"},{"key":"10.1016\/j.intimp.2024.113960_b0515","doi-asserted-by":"crossref","first-page":"112","DOI":"10.1016\/j.jbspin.2013.09.003","article-title":"Prevalence and incidence of juvenile idiopathic arthritis: a systematic review","volume":"81","author":"Thierry","year":"2014","journal-title":"Joint Bone Spine"},{"key":"10.1016\/j.intimp.2024.113960_b0520","doi-asserted-by":"crossref","first-page":"187","DOI":"10.1007\/s40744-016-0040-4","article-title":"Juvenile Idiopathic Arthritis: Diagnosis and Treatment","volume":"3","author":"Giancane","year":"2016","journal-title":"Rheumatol Ther."},{"key":"10.1016\/j.intimp.2024.113960_b0525","doi-asserted-by":"crossref","first-page":"358","DOI":"10.1046\/j.1440-1754.2002.00789.x","article-title":"Parvovirus B19 in the acute arthropathies and juvenile rheumatoid arthritis","volume":"38","author":"O\u011fuz","year":"2002","journal-title":"J Paediatr Child Health."},{"key":"10.1016\/j.intimp.2024.113960_b0530","article-title":"Role of parvovirus B19 infection in juvenile chronic arthritis. Is more investigation needed?","author":"Angelini","year":"200321684","journal-title":"Clin Exp Rheumatol."},{"key":"10.1016\/j.intimp.2024.113960_b0535","first-page":"1336","article-title":"Parvovirus B19 may have a role in the pathogenesis of juvenile idiopathic arthritis","volume":"34","author":"Gonzalez","year":"2007","journal-title":"J Rheumatol."},{"key":"10.1016\/j.intimp.2024.113960_b0540","doi-asserted-by":"crossref","first-page":"512","DOI":"10.1016\/S0002-9343(00)00561-1","article-title":"Transient anticardiolipin antibody syndrome in a patient with parvovirus B19 infection","volume":"109","author":"Reitblat","year":"2000","journal-title":"Am J Med."},{"key":"10.1016\/j.intimp.2024.113960_b0545","doi-asserted-by":"crossref","first-page":"2014","DOI":"10.1128\/JVI.76.4.2014-2018.2002","article-title":"The VP1 unique region of parvovirus B19 and its constituent phospholipase A2-like activity","volume":"76","author":"Dorsch","year":"2002","journal-title":"J Virl."},{"key":"10.1016\/j.intimp.2024.113960_b0550","doi-asserted-by":"crossref","first-page":"13","DOI":"10.1186\/1423-0127-16-13","article-title":"Effects of human parvovirus B19 VP1 unique region protein on macrophage responses","volume":"16","author":"Tzang","year":"2009","journal-title":"J Biomed Sci."},{"key":"10.1016\/j.intimp.2024.113960_b0555","doi-asserted-by":"crossref","first-page":"113","DOI":"10.1016\/j.jaut.2015.08.002","article-title":"Immunogenetics of juvenile idiopathic arthritis: A comprehensive review","volume":"64","author":"Hersh","year":"2015","journal-title":"J Autoimmun."},{"key":"10.1016\/j.intimp.2024.113960_b0560","doi-asserted-by":"crossref","first-page":"200","DOI":"10.1139\/w11-119","article-title":"Genotyping of Human parvovirus B19 among Brazilian patients with hemoglobinopathies","volume":"58","author":"Slavov","year":"2012","journal-title":"Can J Microbiol."},{"key":"10.1016\/j.intimp.2024.113960_b0565","doi-asserted-by":"crossref","first-page":"1652","DOI":"10.1002\/jmv.23358","article-title":"Molecular and phylogenetic analyses of human Parvovirus B19 isolated from Brazilian patients with sickle cell disease and \u03b2-thalassemia major and healthy blood donors","volume":"84","author":"Slavov","year":"2012","journal-title":"J Med Virol."},{"key":"10.1016\/j.intimp.2024.113960_b0570","doi-asserted-by":"crossref","first-page":"176","DOI":"10.1016\/0268-960X(95)90023-3","article-title":"Parvovirus B19 infection and hematopoiesis","volume":"9","author":"Brown","year":"1995","journal-title":"Blood Rev."},{"key":"10.1016\/j.intimp.2024.113960_b0575","doi-asserted-by":"crossref","first-page":"224","DOI":"10.1172\/JCI111195","article-title":"Characterization of a virus that causes transient aplastic crisis","volume":"73","author":"Young","year":"1984","journal-title":"J Clin Invest."},{"key":"10.1016\/j.intimp.2024.113960_b0580","doi-asserted-by":"crossref","first-page":"1","DOI":"10.1016\/1040-8428(94)90040-X","article-title":"Molecular, cellular and clinical aspects of parvovirus B19 infection","volume":"16","author":"Brown","year":"1994","journal-title":"Crit Rev Oncol Hematol."},{"key":"10.1016\/j.intimp.2024.113960_b0585","doi-asserted-by":"crossref","first-page":"287","DOI":"10.1056\/NEJM198707303170506","article-title":"Chronic bone marrow failure due to persistent B19 parvovirus infection","volume":"317","author":"Kurtzman","year":"1987","journal-title":"N Engl J Med."},{"key":"10.1016\/j.intimp.2024.113960_b0590","doi-asserted-by":"crossref","first-page":"247","DOI":"10.1111\/j.1574-695X.2011.00819.x","article-title":"Human parvovirus B19: general considerations and impact on patients with sickle-cell disease and thalassemia and on blood transfusions","volume":"62","author":"Slavov","year":"2011","journal-title":"FEMS Immunol Med Microbiol."},{"key":"10.1016\/j.intimp.2024.113960_b0595","doi-asserted-by":"crossref","first-page":"96","DOI":"10.1186\/s41182-020-00284-x","article-title":"A literature review on the parvovirus B19 infection in sickle cell anemia and \u03b2-thalassemia patients","volume":"48","author":"Soltani","year":"2020","journal-title":"Trop Med Health."},{"key":"10.1016\/j.intimp.2024.113960_b0600","doi-asserted-by":"crossref","unstructured":"dos Santos Brito Silva Furtado M, Viana MB, Hickson Rrios JS, Gontijo RL, Silva CM, do Val Rezende P, et al. Prevalence and incidence of erythrovirus B19 infection in children with sickle cell disease: The impact of viral infection in acute clinical events. J Med Virol. 2016;88:588-95.","DOI":"10.1002\/jmv.24378"},{"key":"10.1016\/j.intimp.2024.113960_b0605","doi-asserted-by":"crossref","first-page":"114","DOI":"10.1126\/science.8211117","article-title":"Erythrocyte P antigen: cellular receptor for B19 parvovirus","volume":"262","author":"Brown","year":"1993","journal-title":"Science"},{"key":"10.1016\/j.intimp.2024.113960_b0610","doi-asserted-by":"crossref","first-page":"1192","DOI":"10.1056\/NEJM199404283301704","article-title":"Resistance to parvovirus B19 infection due to lack of virus receptor (erythrocyte P antigen)","volume":"330","author":"Brown","year":"1994","journal-title":"N Engl J Med."},{"key":"10.1016\/j.intimp.2024.113960_b0615","doi-asserted-by":"crossref","first-page":"36","DOI":"10.1309\/B361-LA0V-UX0X-GJPQ","article-title":"Bone marrow samples from patients with aplastic anemia are not infected with parvovirus B19 and Mycobacterium tuberculosis","volume":"117","author":"Hsu","year":"2002","journal-title":"Am J Clin Pathol."},{"key":"10.1016\/j.intimp.2024.113960_b0620","doi-asserted-by":"crossref","first-page":"83","DOI":"10.1007\/s002770050477","article-title":"Severe aplastic anemia associated with human parvovirus B19 infection in a patient without underlying disease","volume":"78","author":"Osaki","year":"1999","journal-title":"Ann Hematol."},{"key":"10.1016\/j.intimp.2024.113960_b0625","first-page":"669","article-title":"Acquired aplastic anemia: correlation between etiology, pathophysiology, bone marrow histology and prognosis factors","volume":"50","author":"G\u0103man","year":"2009","journal-title":"Rom J Morphol Embryol."},{"key":"10.1016\/j.intimp.2024.113960_b0630","article-title":"Clinical Characteristics and Etiological Spectrum of Pancytopenia in Pediatric Age Group: A Cross-Sectional Outlook From a Developing Country","volume":"14","author":"Zubair","year":"2022","journal-title":"Cureus."},{"key":"10.1016\/j.intimp.2024.113960_b0635","doi-asserted-by":"crossref","first-page":"166","DOI":"10.1002\/ajh.20347","article-title":"Human parvovirus B19 in patients with aplastic anemia","volume":"79","author":"Mishra","year":"2005","journal-title":"Am J Hematol."},{"key":"10.1016\/j.intimp.2024.113960_b0640","doi-asserted-by":"crossref","first-page":"185","DOI":"10.1097\/MPH.0000000000001737","article-title":"Changes in Different Cytokines (IL-2, TNF-alpha, and IFN-gamma) Profile in Acquired Aplastic Anemia Patients: A Study From Eastern India","volume":"42","author":"Dutta","year":"2020","journal-title":"J Pediatr Hematol Oncol."},{"key":"10.1016\/j.intimp.2024.113960_b0645","doi-asserted-by":"crossref","first-page":"3011","DOI":"10.1099\/0022-1317-82-12-3011","article-title":"Circulating tumour necrosis factor-alpha and interferon-gamma are detectable during acute and convalescent parvovirus B19 infection and are associated with prolonged and chronic fatigue","volume":"82","author":"Kerr","year":"2001","journal-title":"J Gen Virol."},{"key":"10.1016\/j.intimp.2024.113960_b0650","doi-asserted-by":"crossref","first-page":"51","DOI":"10.1182\/asheducation-2016.1.51","article-title":"Pure red cell aplasia","volume":"2016","author":"Means","year":"2016","journal-title":"Hematology Am Soc Hematol Educ Program."},{"key":"10.1016\/j.intimp.2024.113960_b0655","doi-asserted-by":"crossref","first-page":"257","DOI":"10.1093\/infdis\/152.2.257","article-title":"Experimental parvoviral infection in humans","volume":"152","author":"Anderson","year":"1985","journal-title":"J Infect Dis."},{"key":"10.1016\/j.intimp.2024.113960_b0660","doi-asserted-by":"crossref","first-page":"218","DOI":"10.1016\/j.siny.2009.01.007","article-title":"Parvovirus B19 infection","volume":"14","author":"Tolfvenstam","year":"2009","journal-title":"Semin Fetal Neonatal Med."},{"key":"10.1016\/j.intimp.2024.113960_b0665","doi-asserted-by":"crossref","first-page":"411","DOI":"10.1007\/s00296-006-0227-z","article-title":"A case of pure red cell aplasia and systemic lupus erythematosus caused by human parvovirus B19 infection","volume":"27","author":"Ideguchi","year":"2007","journal-title":"Rheumatol Int."},{"key":"10.1016\/j.intimp.2024.113960_b0670","article-title":"Recurrent severe anaemia: a rare presentation of parvovirus b19 infection","author":"Singh","year":"2014801","journal-title":"J Clin Diagn Res."},{"key":"10.1016\/j.intimp.2024.113960_b0675","article-title":"Hemolytic Anemia","author":"Baldwin","year":"2024","journal-title":"StatPearls. Treasure Island (FL): Statpearls Publishing LLC."},{"key":"10.1016\/j.intimp.2024.113960_b0680","doi-asserted-by":"crossref","first-page":"2308","DOI":"10.1055\/s-0031-1292044","article-title":"Krause SW","volume":"136","author":"M\u00fcller","year":"2011","journal-title":"Dtsch Med Wochenschr"},{"key":"10.1016\/j.intimp.2024.113960_b0685","doi-asserted-by":"crossref","first-page":"30","DOI":"10.1016\/j.medcli.2022.07.021","article-title":"Autoimmune haemolytic anaemia","volume":"160","author":"Arg\u00fcello Marina","year":"2023","journal-title":"Med Clin (barc)."},{"key":"10.1016\/j.intimp.2024.113960_b0690","article-title":"Parvovirus B19-triggered Acute Hemolytic Anemia and Thrombocytopenia in a Child with Evans Syndrome","volume":"10","author":"Zikidou","year":"2018","journal-title":"Mediterr J Hematol Infect Dis."},{"key":"10.1016\/j.intimp.2024.113960_b0695","doi-asserted-by":"crossref","first-page":"786","DOI":"10.1007\/s13365-017-0562-8","article-title":"Parvovirus B19 infection associated with hemolytic anemia and cranial polyneuropathy","volume":"23","author":"Sequeira","year":"2017","journal-title":"J Neurovirol."},{"key":"10.1016\/j.intimp.2024.113960_b0700","doi-asserted-by":"crossref","first-page":"677","DOI":"10.2169\/internalmedicine.55.5657","article-title":"Autoimmune Hemolytic Anemia Triggered by Infection with Human Parvovirus B19 after Total Abdominal Colectomy for Ulcerative Colitis","volume":"55","author":"Iida","year":"2016","journal-title":"Intern Med."},{"key":"10.1016\/j.intimp.2024.113960_b0705","first-page":"167","article-title":"Parvovirus B19 infection associated with reticulocytopenia and chronic autoimmune hemolytic anemia","volume":"11","author":"Smith","year":"1989","journal-title":"Am J Pediatr Hematol Oncol."},{"key":"10.1016\/j.intimp.2024.113960_b0710","first-page":"2624","article-title":"A case of recurrent autoimmune hemolytic anemia during remission associated with acute pure red cell aplasia and hemophagocytic syndrome due to human parvovirus B19 infection successfully treated by steroid pulse therapy with a review of the literature","volume":"7","author":"Sekiguchi","year":"2014","journal-title":"Int J Clin Exp Pathol."},{"key":"10.1016\/j.intimp.2024.113960_b0715","doi-asserted-by":"crossref","first-page":"178","DOI":"10.1097\/00043426-199605000-00017","article-title":"Acute transient hemolytic anemia with a positive Donath-Landsteiner test following parvovirus B19 infection","volume":"18","author":"Chambers","year":"1996","journal-title":"J Pediatr Hematol Oncol."},{"key":"10.1016\/j.intimp.2024.113960_b0720","first-page":"410","article-title":"Idiopathic thrombocytopenic purpura. Contemp Clin","volume":"5","author":"Kayal","year":"2014","journal-title":"Dent"},{"key":"10.1016\/j.intimp.2024.113960_b0725","doi-asserted-by":"crossref","first-page":"69","DOI":"10.1053\/tmrv.2003.50004","article-title":"Cellular immune mechanisms in autoimmune thrombocytopenic purpura: An update","volume":"17","author":"Coopamah","year":"2003","journal-title":"Transfus Med Rev."},{"key":"10.1016\/j.intimp.2024.113960_b0730","doi-asserted-by":"crossref","first-page":"S2","DOI":"10.1053\/j.seminhematol.2008.12.005","article-title":"Pathobiology of secondary immune thrombocytopenia","volume":"46","author":"Cines","year":"2009","journal-title":"Semin Hematol."},{"key":"10.1016\/j.intimp.2024.113960_b0735","first-page":"999","article-title":"Association of human parvovirus B19 infection and childhood idiopathic thrombocytopenic purpura: a meta analysis of Chinese literatures","volume":"11","author":"Zhang","year":"2009","journal-title":"Zhongguo Dang Dai Er Ke Za Zhi"},{"key":"10.1016\/j.intimp.2024.113960_b0740","first-page":"314","article-title":"Childhood idiopathic thrombocytopenic purpura: association with human parvovirus B19 infection","volume":"16","author":"Murray","year":"1994","journal-title":"Am J Pediatr Hematol Oncol."},{"key":"10.1016\/j.intimp.2024.113960_b0745","doi-asserted-by":"crossref","first-page":"934","DOI":"10.1016\/S0168-8278(97)80334-0","article-title":"Human parvovirus B19 infection associated with idiopathic thrombocytopenic purpura in a child following liver transplantation","volume":"27","author":"Assy","year":"1997","journal-title":"J Hepatol."},{"key":"10.1016\/j.intimp.2024.113960_b0750","doi-asserted-by":"crossref","first-page":"421","DOI":"10.1080\/08880010490457141","article-title":"Human parvovirus B19 associated with idiopathic thrombocytopenic purpura","volume":"21","author":"Aktepe","year":"2004","journal-title":"Pediatr Hematol Oncol."},{"key":"10.1016\/j.intimp.2024.113960_b0755","first-page":"74","article-title":"Weekly long-term intravenous immunoglobulin for refractory parvovirus B19 and Epstein-Barr virus-induced immune thrombocytopenic purpura","volume":"50","author":"Tavil","year":"2008","journal-title":"Turk J Pediatr."},{"key":"10.1016\/j.intimp.2024.113960_b0760","doi-asserted-by":"crossref","first-page":"404","DOI":"10.3389\/fmed.2020.00404","article-title":"Immune Thrombocytopenia in a Very Elderly Patient With Covid-19","volume":"7","author":"Hindilerden","year":"2020","journal-title":"Front Med (lausanne)."},{"key":"10.1016\/j.intimp.2024.113960_b0765","doi-asserted-by":"crossref","first-page":"614","DOI":"10.1111\/j.1651-2227.1999.tb00009.x","article-title":"Role of parvovirus B19 infection in childhood idiopathic thrombocytopenic purpura","volume":"88","author":"Heegaard","year":"1999","journal-title":"Acta Paediatr."},{"key":"10.1016\/j.intimp.2024.113960_b0770","doi-asserted-by":"crossref","first-page":"553","DOI":"10.1097\/00007890-200008150-00031","article-title":"Splenectomy for idiopathic thrombocytopenic purpura after living-related liver transplantation","volume":"70","author":"Kita","year":"2000","journal-title":"Transplantation"},{"key":"10.1016\/j.intimp.2024.113960_b0775","first-page":"597","article-title":"Ayyildiz A","volume":"41","author":"Uslu","year":"2007","journal-title":"Mikrobiyol Bul"},{"key":"10.1016\/j.intimp.2024.113960_b0780","doi-asserted-by":"crossref","first-page":"354","DOI":"10.1111\/tid.12067","article-title":"Preemptive intravenous immunoglobulin allows safe and timely administration of antineoplastic therapies in patients with multiple myeloma and parvovirus B19 disease","volume":"15","author":"Katragadda","year":"2013","journal-title":"Transpl Infect Dis."},{"key":"10.1016\/j.intimp.2024.113960_b0785","doi-asserted-by":"crossref","first-page":"809","DOI":"10.1016\/S0031-3955(05)70434-X","article-title":"Diverse hematologic effects of parvovirus B19 infection","volume":"43","author":"Mustafa","year":"1996","journal-title":"Pediatr Clin North Am."},{"key":"10.1016\/j.intimp.2024.113960_b0790","doi-asserted-by":"crossref","first-page":"118","DOI":"10.1046\/j.1423-0410.2000.79201181.x","article-title":"Parvovirus B19 in idiopathic thrombocytopenic purpura","volume":"79","author":"Wehmeier","year":"2000","journal-title":"Vox Sang."},{"key":"10.1016\/j.intimp.2024.113960_b0795","doi-asserted-by":"crossref","first-page":"173","DOI":"10.1016\/S1386-6532(00)00179-7","article-title":"Chronic autoimmune thrombopenia\/neutropenia in a boy with persistent parvovirus B19 infection","volume":"20","author":"Scheurlen","year":"2001","journal-title":"J Clin Virol."},{"key":"10.1016\/j.intimp.2024.113960_b0800","doi-asserted-by":"crossref","first-page":"278","DOI":"10.1016\/j.autrev.2006.09.006","article-title":"Human parvovirus B19 infection and antiphospholipid antibodies","volume":"6","author":"von Landenberg","year":"2007","journal-title":"Autoimmun Rev."},{"key":"10.1016\/j.intimp.2024.113960_b0805","first-page":"217","article-title":"Immune thrombocytopenic purpura as sole manifestation in a case of acute hepatitis A","volume":"16","author":"Tanir","year":"2005","journal-title":"Turk J Gastroenterol."},{"key":"10.1016\/j.intimp.2024.113960_b0810","doi-asserted-by":"crossref","first-page":"530","DOI":"10.1111\/j.1365-2141.1993.tb03113.x","article-title":"Parvovirus B19-associated haemophagocytosis in Evans syndrome: aplastic crisis accompanied by severe thrombocytopenia","volume":"84","author":"Uike","year":"1993","journal-title":"Br J Haematol."},{"key":"10.1016\/j.intimp.2024.113960_b0815","doi-asserted-by":"crossref","first-page":"177","DOI":"10.1016\/j.meegid.2017.11.021","article-title":"Incidence and progression of Parvovirus B19 infection and molecular changes in circulating B19V strains in children with haematological malignancy: A follow up study","volume":"57","author":"Jain","year":"2018","journal-title":"Infect Genet Evol."},{"key":"10.1016\/j.intimp.2024.113960_b0820","article-title":"Prevalence, Cell Tropism, and Clinical Impact of Human Parvovirus Persistence in Adenomatous, Cancerous, Inflamed, and Healthy Intestinal Mucosa","volume":"13","author":"Xu","year":"2022","journal-title":"Front Microbiol."},{"key":"10.1016\/j.intimp.2024.113960_b0825","doi-asserted-by":"crossref","first-page":"E31","DOI":"10.1111\/1469-0691.12058","article-title":"Investigation of human parvovirus B19 occurrence and genetic variability in different leukaemia entities","volume":"19","author":"da Costa","year":"2013","journal-title":"Clin Microbiol Infect."},{"key":"10.1016\/j.intimp.2024.113960_b0830","doi-asserted-by":"crossref","first-page":"1336","DOI":"10.1111\/j.1469-0691.2010.03355.x","article-title":"Impact of parvovirus B19 infection on paediatric patients with haematological and\/or oncological disorders","volume":"17","author":"Jitschin","year":"2011","journal-title":"Clin Microbiol Infect."},{"key":"10.1016\/j.intimp.2024.113960_b0835","doi-asserted-by":"crossref","first-page":"77","DOI":"10.1007\/s12098-017-2428-8","article-title":"Prevalence of Parvovirus B19V in Hematological Malignancies and Chronic Anemia","volume":"85","author":"Jain","year":"2018","journal-title":"Indian J Pediatr."},{"key":"10.1016\/j.intimp.2024.113960_b0840","doi-asserted-by":"crossref","first-page":"1656","DOI":"10.1245\/s10434-022-12958-3","article-title":"ASO Author Reflections: A Possible New Etiology of Thymoma-Associated Myasthenia Gravis-Human Parvovirus B19","volume":"30","author":"Gong","year":"2023","journal-title":"Ann Surg Oncol."},{"key":"10.1016\/j.intimp.2024.113960_b0845","doi-asserted-by":"crossref","unstructured":"Gong L, Li Y, Li X, Tu Q, Mou X, Wang S, et al. Detection of human parvovirus B19 infection in the thymus of patients with thymic hyperplasia-associated myasthenia gravis. Clin Microbiol Infect. 2019;25:109.e7-.e12.","DOI":"10.1016\/j.cmi.2018.03.036"},{"key":"10.1016\/j.intimp.2024.113960_b0850","doi-asserted-by":"crossref","first-page":"1646","DOI":"10.1245\/s10434-022-12936-9","article-title":"Human Parvovirus B19 May Be a Risk Factor in Myasthenia Gravis with Thymoma","volume":"30","author":"Gong","year":"2023","journal-title":"Ann Surg Oncol."},{"key":"10.1016\/j.intimp.2024.113960_b0855","doi-asserted-by":"crossref","DOI":"10.1002\/jmv.29269","article-title":"Molecular investigation of some DNA viruses in mucosal melanoma: Case-control study","volume":"95","author":"Arvia","year":"2023","journal-title":"J Med Virol."},{"key":"10.1016\/j.intimp.2024.113960_b0860","doi-asserted-by":"crossref","first-page":"51","DOI":"10.1186\/s13027-023-00528-5","article-title":"Human parvovirus B19 infection in malignant and benign tissue specimens of different head and neck anatomical subsites","volume":"18","author":"Abuei","year":"2023","journal-title":"Infect Agent Cancer."},{"key":"10.1016\/j.intimp.2024.113960_b0865","article-title":"Overall prevalence of human parvovirus B19 among blood donors in mainland China: A PRISMA-compliant meta-analysis","volume":"99","author":"Li","year":"2020","journal-title":"Medicine (Baltimore)"},{"key":"10.1016\/j.intimp.2024.113960_b0870","doi-asserted-by":"crossref","first-page":"e217","DOI":"10.1097\/TXD.0000000000000731","article-title":"Parvovirus B19 in the Context of Hematopoietic Stem Cell Transplantation: Evaluating Cell Donors and Recipients","volume":"3","author":"Gama","year":"2017","journal-title":"Transplant Direct."},{"key":"10.1016\/j.intimp.2024.113960_b0875","doi-asserted-by":"crossref","first-page":"496","DOI":"10.4314\/ahs.v18i3.5","article-title":"Seroprevalence of parvovirus B19 in blood donors: the risks and challenges of blood transfusion in Zambia in the era of HIV\/AIDS at the Kitwe Central Hospital, blood bank","volume":"18","author":"Chirambo-Kalolekesha","year":"2018","journal-title":"Afr Health Sci."},{"key":"10.1016\/j.intimp.2024.113960_b0880","doi-asserted-by":"crossref","first-page":"63","DOI":"10.1007\/s10528-019-09928-y","article-title":"Upregulation of Pro-inflammatory Cytokine Genes by Parvovirus B19 in Human Bone Marrow Mesenchymal Stem Cells","volume":"58","author":"Amiri","year":"2020","journal-title":"Biochem Genet."},{"key":"10.1016\/j.intimp.2024.113960_b0885","doi-asserted-by":"crossref","first-page":"77","DOI":"10.1016\/j.cca.2008.05.012","article-title":"Up-regulation of adhesion molecule expression and induction of TNF-alpha on vascular endothelial cells by antibody against human parvovirus B19 VP1 unique region protein","volume":"395","author":"Tzang","year":"2008","journal-title":"Clin Chim Acta."},{"key":"10.1016\/j.intimp.2024.113960_b0890","doi-asserted-by":"crossref","first-page":"208","DOI":"10.1080\/21505594.2017.1385691","article-title":"Antigenicity analysis of human parvovirus B19-VP1u protein in the induction of anti-phospholipid syndrome","volume":"9","author":"Lin","year":"2018","journal-title":"Virulence"},{"key":"10.1016\/j.intimp.2024.113960_b0895","first-page":"1320","article-title":"Effects of antibodies against human parvovirus B19 on angiogenic signaling","volume":"21","author":"Su","year":"2020","journal-title":"Mol Med Rep."},{"key":"10.1016\/j.intimp.2024.113960_b0900","doi-asserted-by":"crossref","first-page":"1084","DOI":"10.1016\/j.cca.2010.04.004","article-title":"The association of anti-parvovirus B19-VP1 unique region antibodies with antiphospholipid antibodies in patients with antiphospholipid syndrome","volume":"411","author":"Chen","year":"2010","journal-title":"Clin Chim Acta."},{"key":"10.1016\/j.intimp.2024.113960_b0905","doi-asserted-by":"crossref","first-page":"1520","DOI":"10.1177\/0961203316640912","article-title":"Systematic review of case reports of antiphospholipid syndrome following infection","volume":"25","author":"Abdel-Wahab","year":"2016","journal-title":"Lupus"},{"key":"10.1016\/j.intimp.2024.113960_b0910","doi-asserted-by":"crossref","first-page":"256","DOI":"10.1053\/sarh.2002.28303","article-title":"Viral infections and antiphospholipid antibodies","volume":"31","author":"Uthman","year":"2002","journal-title":"Semin Arthritis Rheum."},{"key":"10.1016\/j.intimp.2024.113960_b0915","doi-asserted-by":"crossref","first-page":"3099","DOI":"10.1002\/art.10580","article-title":"Detection of parvovirus B19 DNA by polymerase chain reaction in giant cell arteritis: a case-control study","volume":"46","author":"Salvarani","year":"2002","journal-title":"Arthritis Rheum."},{"key":"10.1016\/j.intimp.2024.113960_b0920","doi-asserted-by":"crossref","first-page":"1123","DOI":"10.1093\/clinids\/22.6.1123","article-title":"Association of parvovirus B19 infection with giant cell arteritis","volume":"22","author":"Staud","year":"1996","journal-title":"Clin Infect Dis."},{"key":"10.1016\/j.intimp.2024.113960_b0925","doi-asserted-by":"crossref","first-page":"1255","DOI":"10.1002\/1529-0131(199906)42:6<1255::AID-ANR23>3.0.CO;2-P","article-title":"The role of parvovirus B19 in the pathogenesis of giant cell arteritis: a preliminary evaluation","volume":"42","author":"Gabriel","year":"1999","journal-title":"Arthritis Rheum."},{"key":"10.1016\/j.intimp.2024.113960_b0930","doi-asserted-by":"crossref","first-page":"780","DOI":"10.1136\/ard.2004.025320","article-title":"Human parvovirus B19, varicella zoster virus, and human herpes virus 6 in temporal artery biopsy specimens of patients with giant cell arteritis: analysis with quantitative real time polymerase chain reaction","volume":"64","author":"Alvarez-Lafuente","year":"2005","journal-title":"Ann Rheum Dis."},{"key":"10.1016\/j.intimp.2024.113960_b0935","doi-asserted-by":"crossref","first-page":"160","DOI":"10.1016\/S0151-9638(07)91610-5","article-title":"Cribier B","volume":"134","author":"Engel","year":"2007","journal-title":"Ann Dermatol Venereol"},{"key":"10.1016\/j.intimp.2024.113960_b0940","doi-asserted-by":"crossref","first-page":"9917","DOI":"10.3390\/ijms25189917","article-title":"Parvovirus B19 Infection Is Associated with the Formation of Neutrophil Extracellular Traps and Thrombosis: A Possible Linkage of the VP1 Unique Region","volume":"25","author":"Tzang","year":"2024","journal-title":"Int. J. Mol. Sci."},{"key":"10.1016\/j.intimp.2024.113960_b0945","doi-asserted-by":"crossref","first-page":"294","DOI":"10.1016\/j.semarthrit.2003.09.008","article-title":"Are polymyalgia rheumatica and giant cell arteritis the same disease?","volume":"33","author":"Cantini","year":"2004","journal-title":"Semin Arthritis Rheum."},{"key":"10.1016\/j.intimp.2024.113960_b0950","doi-asserted-by":"crossref","first-page":"2125","DOI":"10.1016\/j.jid.2019.03.1144","article-title":"Effects of Parvovirus B19 In Vitro Infection on Monocytes from Patients with Systemic Sclerosis: Enhanced Inflammatory Pathways by Caspase-1 Activation and Cytokine Production","volume":"139","author":"Zakrzewska","year":"2019","journal-title":"J Invest Dermatol."},{"key":"10.1016\/j.intimp.2024.113960_b0955","doi-asserted-by":"crossref","first-page":"15294","DOI":"10.3390\/ijms242015294","article-title":"Effect of the Functional VP1 Unique Region of Human Parvovirus B19 in Causing Skin Fibrosis of Systemic Sclerosis","volume":"24","author":"Chen","year":"2023","journal-title":"Int J Mol Sci."},{"key":"10.1016\/j.intimp.2024.113960_b0960","doi-asserted-by":"crossref","first-page":"1192","DOI":"10.3906\/sag-1404-150","article-title":"The prevalence of infectious agents in patients with systemic sclerosis","volume":"45","author":"Bilgin","year":"2015","journal-title":"Turk J Med Sci."},{"key":"10.1016\/j.intimp.2024.113960_b0965","doi-asserted-by":"crossref","first-page":"694","DOI":"10.1097\/00002281-200211000-00011","article-title":"The role of infectious agents in the pathogenesis of systemic sclerosis","volume":"14","author":"Hamamdzic","year":"2002","journal-title":"Curr Opin Rheumatol."},{"key":"10.1016\/j.intimp.2024.113960_b0970","doi-asserted-by":"crossref","first-page":"36","DOI":"10.1016\/j.autrev.2008.07.022","article-title":"Systemic sclerosis and infections","volume":"8","author":"Randone","year":"2008","journal-title":"Autoimmun Rev."},{"key":"10.1016\/j.intimp.2024.113960_b0975","first-page":"348","article-title":"Infectious disease as aetiological factor in the pathogenesis of systemic sclerosis","volume":"68","author":"Radi\u0107","year":"2010","journal-title":"Neth J Med."},{"key":"10.1016\/j.intimp.2024.113960_b0980","first-page":"3","article-title":"Role of viral infections in the etiopathogenesis of systemic sclerosis","volume":"31","author":"Moroncini","year":"2013","journal-title":"Clin Exp Rheumatol."},{"key":"10.1016\/j.intimp.2024.113960_b0985","doi-asserted-by":"crossref","first-page":"1","DOI":"10.1007\/s11926-015-0552-x","article-title":"Fresh Insights into Disease Etiology and the Role of Microbial Pathogens","volume":"18","author":"Farina","year":"2016","journal-title":"Curr Rheumatol Rep."},{"key":"10.1016\/j.intimp.2024.113960_b0990","doi-asserted-by":"crossref","first-page":"1091","DOI":"10.1111\/j.0007-0963.2004.05930.x","article-title":"Increased prevalence of human parvovirus B19 DNA in systemic sclerosis skin","volume":"150","author":"Ohtsuka","year":"2004","journal-title":"Br J Dermatol."},{"key":"10.1016\/j.intimp.2024.113960_b0995","doi-asserted-by":"crossref","first-page":"109","DOI":"10.2174\/092986606775101715","article-title":"Autoantibody reaction to myelin basic protein by plasma parvovirus B19 IgG in MS patients","volume":"13","author":"Thomas","year":"2006","journal-title":"Protein Pept Lett."},{"key":"10.1016\/j.intimp.2024.113960_b1000","doi-asserted-by":"crossref","first-page":"60","DOI":"10.1097\/DAD.0000000000001690","article-title":"Flame Figures in Linear Immunoglobulin A Bullous Dermatosis Secondary to Parvovirus B19 Infection","volume":"43","author":"Garc\u00eda-Gil","year":"2021","journal-title":"Am J Dermatopathol."},{"key":"10.1016\/j.intimp.2024.113960_b1005","doi-asserted-by":"crossref","first-page":"231","DOI":"10.1007\/s00403-006-0678-9","article-title":"A high prevalence of parvovirus B19 DNA in patients with psoriasis","volume":"298","author":"Yazici","year":"2006","journal-title":"Arch Dermatol Res."},{"key":"10.1016\/j.intimp.2024.113960_b1010","doi-asserted-by":"crossref","first-page":"193","DOI":"10.3892\/mmr.2023.13080","article-title":"Celastrol attenuates human parvovirus B19 NS1\u2011induced NLRP3 inflammasome activation in macrophages","volume":"28","author":"Huang","year":"2023","journal-title":"Mol Med Rep."},{"key":"10.1016\/j.intimp.2024.113960_b1015","doi-asserted-by":"crossref","first-page":"773","DOI":"10.1016\/S1474-4422(07)70196-5","article-title":"Clinical features and viral serologies in children with multiple sclerosis: a multinational observational study","volume":"6","author":"Banwell","year":"2007","journal-title":"Lancet Neurol."},{"key":"10.1016\/j.intimp.2024.113960_b1020","doi-asserted-by":"crossref","first-page":"50","DOI":"10.3389\/fendo.2017.00050","article-title":"Environmental Issues in Thyroid Diseases","volume":"8","author":"Ferrari","year":"2017","journal-title":"Front Endocrinol (lausanne)."},{"key":"10.1016\/j.intimp.2024.113960_b1025","doi-asserted-by":"crossref","first-page":"529","DOI":"10.1007\/s11154-016-9361-4","article-title":"The role of human parvovirus B19 and hepatitis C virus in the development of thyroid disorders","volume":"17","author":"Fallahi","year":"2016","journal-title":"Rev Endocr Metab Disord."},{"key":"10.1016\/j.intimp.2024.113960_b1030","doi-asserted-by":"crossref","DOI":"10.3389\/fendo.2022.938633","article-title":"High Prevalence of Common Human Viruses in Thyroid Tissue","volume":"13","author":"Weider","year":"2022","journal-title":"Front Endocrinol (lausanne)."},{"key":"10.1016\/j.intimp.2024.113960_b1035","first-page":"1998","article-title":"Association between Parvovirus B19 and thyroid\/celiac autoantibodies among T1DM pediatric patients","volume":"28","author":"Chandramoorthy","year":"2024","journal-title":"Eur Rev Med Pharmacol Sci."},{"key":"10.1016\/j.intimp.2024.113960_b1040","doi-asserted-by":"crossref","first-page":"774","DOI":"10.3390\/medicina55120774","article-title":"Presence of B19V in Patients with Thyroid Gland Disorders","volume":"55","author":"Gravelsina","year":"2019","journal-title":"Medicina (kaunas)."},{"key":"10.1016\/j.intimp.2024.113960_b1045","doi-asserted-by":"crossref","first-page":"411","DOI":"10.1089\/thy.2010.0307","article-title":"Parvovirus B19 infection in Hashimoto's thyroiditis, papillary thyroid carcinoma, and anaplastic thyroid carcinoma","volume":"21","author":"Adamson","year":"2011","journal-title":"Thyroid"},{"key":"10.1016\/j.intimp.2024.113960_b1050","first-page":"75","article-title":"Zhang W","volume":"36","author":"Jia","year":"2020","journal-title":"Xi Bao Yu Fen Zi Mian Yi Xue Za Zhi"},{"key":"10.1016\/j.intimp.2024.113960_b1055","doi-asserted-by":"crossref","DOI":"10.5812\/ijem.115592","article-title":"Parvovirus B19 Infection Is Associated with Autoimmune Thyroid Disease in Adults","volume":"19","author":"Heidari","year":"2021","journal-title":"Int J Endocrinol Metab."},{"key":"10.1016\/j.intimp.2024.113960_b1060","doi-asserted-by":"crossref","first-page":"483","DOI":"10.3109\/08916934.2010.547891","article-title":"Experimental autoimmune thyroiditis in human parvovirus B19 transgenic mice","volume":"44","author":"Mori","year":"2011","journal-title":"Autoimmunity"},{"key":"10.1016\/j.intimp.2024.113960_b1065","doi-asserted-by":"crossref","first-page":"5050","DOI":"10.3390\/jcm12155050","article-title":"Advancing Precision Medicine in Myocarditis: Current Status and Future Perspectives in Endomyocardial Biopsy-Based Diagnostics and Therapeutic Approaches","volume":"12","author":"Baumeier","year":"2023","journal-title":"J Clin Med."},{"key":"10.1016\/j.intimp.2024.113960_b1070","doi-asserted-by":"crossref","first-page":"22354","DOI":"10.1038\/s41598-020-78597-4","article-title":"Detection of parvovirus mRNAs as markers for viral activity in endomyocardial biopsy-based diagnosis of patients with unexplained heart failure","volume":"10","author":"Pietsch","year":"2020","journal-title":"Sci Rep-Uk."},{"key":"10.1016\/j.intimp.2024.113960_b1075","doi-asserted-by":"crossref","first-page":"1898","DOI":"10.3390\/biomedicines9121898","article-title":"Transcriptional Active Parvovirus B19 Infection Predicts Adverse Long-Term Outcome in Patients with Non-Ischemic Cardiomyopathy","volume":"9","author":"Escher","year":"2021","journal-title":"Biomedicines."},{"key":"10.1016\/j.intimp.2024.113960_b1080","article-title":"Characterization of rhinovirus C from a 4-year-old boy with acute onset dilated cardiomyopathy in Jakarta","volume":"5","author":"Wiyatno","year":"2018","journal-title":"Indonesia. JMM Case Rep."},{"key":"10.1016\/j.intimp.2024.113960_b1085","doi-asserted-by":"crossref","first-page":"4","DOI":"10.1016\/j.idcr.2018.02.008","article-title":"Cytomegalovirus myocarditis in a patient with systemic lupus erythematosus (SLE) successfully treated with ganciclovir","volume":"12","author":"Saraca","year":"2018","journal-title":"Idcases."},{"key":"10.1016\/j.intimp.2024.113960_b1090","doi-asserted-by":"crossref","first-page":"444","DOI":"10.3390\/v14020444","article-title":"Interferon-\u03b2 Suppresses Transcriptionally Active Parvovirus B19 Infection in Viral Cardiomyopathy: A Subgroup Analysis of the BICC-Trial","volume":"14","author":"Schultheiss","year":"2022","journal-title":"Viruses"},{"key":"10.1016\/j.intimp.2024.113960_b1095","doi-asserted-by":"crossref","first-page":"1928","DOI":"10.3390\/jcm10091928","article-title":"Nucleoside Analogue Reverse Transcriptase Inhibitors Improve Clinical Outcome in Transcriptional Active Human Parvovirus B19-Positive Patients","volume":"10","author":"Schultheiss","year":"2021","journal-title":"J Clin Med."},{"key":"10.1016\/j.intimp.2024.113960_b1100","doi-asserted-by":"crossref","first-page":"233","DOI":"10.1007\/s00392-021-01955-3","article-title":"Fulminant parvovirus B19 myocarditis after chemotherapy: full recovery after antiviral therapy with tenofovir","volume":"111","author":"Koenig","year":"2022","journal-title":"Clin Res Cardiol."},{"key":"10.1016\/j.intimp.2024.113960_b1105","doi-asserted-by":"crossref","first-page":"2045","DOI":"10.1007\/s00431-022-04406-x","article-title":"Parvovirus B19 myocarditis in children: a diagnostic and therapeutic approach","volume":"181","author":"Esmel-Vilomara","year":"2022","journal-title":"Eur J Pediatr."},{"key":"10.1016\/j.intimp.2024.113960_b1110","doi-asserted-by":"crossref","first-page":"862","DOI":"10.1111\/jcpt.13357","article-title":"Paediatric viral myocarditis successfully treated with interferon beta-1b and corticoids","volume":"46","author":"Siguero","year":"2021","journal-title":"J Clin Pharm Ther."},{"key":"10.1016\/j.intimp.2024.113960_b1115","doi-asserted-by":"crossref","first-page":"763","DOI":"10.1007\/s00392-016-0986-9","article-title":"Betaferon in chronic viral cardiomyopathy (BICC) trial: Effects of interferon-\u03b2 treatment in patients with chronic viral cardiomyopathy","volume":"105","author":"Schultheiss","year":"2016","journal-title":"Clin Res Cardiol."},{"key":"10.1016\/j.intimp.2024.113960_b1120","doi-asserted-by":"crossref","first-page":"936","DOI":"10.1086\/650700","article-title":"Interferon Beta Modulates Endothelial Damage in Patients with Cardiac Persistence of Human Parvovirus B19 Infection","volume":"201","author":"Schmidt-Lucke","year":"2010","journal-title":"J Infect Dis."},{"key":"10.1016\/j.intimp.2024.113960_b1125","doi-asserted-by":"crossref","first-page":"659","DOI":"10.3390\/v11070659","article-title":"Advances in the Development of Antiviral Strategies against Parvovirus B19","volume":"11","author":"Manaresi","year":"2019","journal-title":"Viruses"},{"key":"10.1016\/j.intimp.2024.113960_b1130","doi-asserted-by":"crossref","first-page":"E6166","DOI":"10.1073\/pnas.1706359114","article-title":"Intestinal virome changes precede autoimmunity in type I diabetes-susceptible children","volume":"114","author":"Zhao","year":"2017","journal-title":"Proc Natl Acad Sci U S A."},{"key":"10.1016\/j.intimp.2024.113960_b1135","doi-asserted-by":"crossref","first-page":"1778","DOI":"10.1111\/j.1464-5491.2005.01708.x","article-title":"Human parvovirus B19 infection in children with new onset Type 1 diabetes mellitus","volume":"22","author":"O'Brayan","year":"2005","journal-title":"Diabet Med."},{"key":"10.1016\/j.intimp.2024.113960_b1140","doi-asserted-by":"crossref","first-page":"700","DOI":"10.7326\/0003-4819-125-8-199610150-00030","article-title":"Insulin-dependent diabetes mellitus associated with parvovirus B19 infection","volume":"125","author":"Kasuga","year":"1996","journal-title":"Ann Intern Med."},{"key":"10.1016\/j.intimp.2024.113960_b1145","doi-asserted-by":"crossref","first-page":"145","DOI":"10.2337\/db16-0462","article-title":"A Critical Role for the Type I Interferon Receptor in Virus-Induced Autoimmune Diabetes in Rats","volume":"66","author":"Qaisar","year":"2017","journal-title":"Diabetes"},{"key":"10.1016\/j.intimp.2024.113960_b1150","doi-asserted-by":"crossref","first-page":"1697","DOI":"10.1111\/j.1600-6143.2004.00557.x","article-title":"Cytomegalovirus prevalence and transmission after islet allograft transplant in patients with type 1 diabetes mellitus","volume":"4","author":"Hafiz","year":"2004","journal-title":"Am J Transplant."},{"key":"10.1016\/j.intimp.2024.113960_b1155","doi-asserted-by":"crossref","first-page":"1718","DOI":"10.1097\/01.tp.0000187881.97068.77","article-title":"Immunosuppression and procedure-related complications in 26 patients with type 1 diabetes mellitus receiving allogeneic islet cell transplantation","volume":"80","author":"Hafiz","year":"2005","journal-title":"Transplantation"},{"key":"10.1016\/j.intimp.2024.113960_b1160","doi-asserted-by":"crossref","DOI":"10.3389\/fcimb.2022.1083839","article-title":"Human parvovirus B19 infection in hospitalized patients suspected of infection with pathogenic microorganism","volume":"12","author":"Guo","year":"2022","journal-title":"Front Cell Infect Microbiol."},{"key":"10.1016\/j.intimp.2024.113960_b1165","doi-asserted-by":"crossref","unstructured":"de Andrade da Silva R, Cremaschi RC, Rebello Pinho JR, de Oliveira JB, Coelho FM. Guillain-Barr\u00e9 syndrome-the challenge of unrecognized triggers. Neurol Sci. 2019;40:2403-4.","DOI":"10.1007\/s10072-019-03926-z"},{"key":"10.1016\/j.intimp.2024.113960_b1170","article-title":"Diagnosis of Peripheral Facial Palsy Associated with Parvovirus B19 Infection by Polymerase Chain Reaction","volume":"2022","author":"Fukuta","year":"2022","journal-title":"Case Rep Pediatr."},{"key":"10.1016\/j.intimp.2024.113960_b1175","first-page":"471","article-title":"A case of Guillain-Barr\u00e9 syndrome (GBS) following human parvovirus B19 infection","volume":"40","author":"Yamaoka","year":"2000","journal-title":"Rinsho Shinkeigaku"},{"key":"10.1016\/j.intimp.2024.113960_b1180","doi-asserted-by":"crossref","first-page":"717","DOI":"10.1016\/S0140-6736(16)00339-1","article-title":"Guillain-Barre syndrome","volume":"388","author":"Willison","year":"2016","journal-title":"Lancet"},{"key":"10.1016\/j.intimp.2024.113960_b1185","doi-asserted-by":"crossref","first-page":"713","DOI":"10.1016\/j.revmed.2022.08.005","article-title":"Parvovirus B19 infections in adults","volume":"43","author":"Jacquot","year":"2022","journal-title":"Rev Med Interne."},{"key":"10.1016\/j.intimp.2024.113960_b1190","doi-asserted-by":"crossref","first-page":"289","DOI":"10.1016\/j.revmed.2013.04.015","article-title":"Clinical and biological manifestations in primary parvovirus B19 infection in immunocompetent adult: a retrospective study of 26 cases","volume":"35","author":"Parra","year":"2014","journal-title":"Rev Med Interne."},{"key":"10.1016\/j.intimp.2024.113960_b1195","doi-asserted-by":"crossref","first-page":"280","DOI":"10.1177\/0883073813499824","article-title":"Acute transverse myelitis associated with human parvovirus b19 infection","volume":"29","author":"Suzuki","year":"2014","journal-title":"J Child Neurol."},{"key":"10.1016\/j.intimp.2024.113960_b1200","doi-asserted-by":"crossref","first-page":"584","DOI":"10.3390\/brainsci12050584","article-title":"The Clinical Spectrum of Autoimmune-Mediated Neurological Diseases in Paediatric Population","volume":"12","author":"Lubarski","year":"2022","journal-title":"Brain Sci."},{"key":"10.1016\/j.intimp.2024.113960_b1205","doi-asserted-by":"crossref","DOI":"10.3389\/fimmu.2024.1377952","article-title":"The relationship between infectious agents and juvenile dermatomyositis: a narrative update from the pediatric perspective","volume":"15","author":"Sassetti","year":"2024","journal-title":"Front Immunol."},{"key":"10.1016\/j.intimp.2024.113960_b1210","doi-asserted-by":"crossref","first-page":"430","DOI":"10.1093\/clinids\/21.2.430","article-title":"Juvenile dermatomyositis in a child infected with human parvovirus B19","volume":"21","author":"Lewkonia","year":"1995","journal-title":"Clin Infect Dis."},{"key":"10.1016\/j.intimp.2024.113960_b1215","doi-asserted-by":"crossref","first-page":"349","DOI":"10.1093\/rheumatology\/keg085","article-title":"Lack of evidence for a direct involvement of muscle infection by parvovirus B19 in the pathogenesis of inflammatory myopathies: a follow-up study","volume":"42","author":"Chevrel","year":"2003","journal-title":"Rheumatology (Oxford)"},{"key":"10.1016\/j.intimp.2024.113960_b1220","first-page":"2170","article-title":"Parvovirus B19 and onset of juvenile dermatomyositis","volume":"294","author":"Mamyrova","year":"2005","journal-title":"JAMA"},{"key":"10.1016\/j.intimp.2024.113960_b1225","doi-asserted-by":"crossref","first-page":"744","DOI":"10.1001\/archderm.1995.01690180124033","article-title":"Acute generalized livedo reticularis with myasthenialike syndrome revealing parvovirus B19 primary infection","volume":"131","author":"Dereure","year":"1995","journal-title":"Arch Dermatol."},{"key":"10.1016\/j.intimp.2024.113960_b1230","doi-asserted-by":"crossref","first-page":"34","DOI":"10.1532\/LH96.06036","article-title":"Parvovirus B19 infection after plasma exchange for myasthenia gravis","volume":"13","author":"Bianchi","year":"2007","journal-title":"Lab Hematol."},{"key":"10.1016\/j.intimp.2024.113960_b1235","doi-asserted-by":"crossref","DOI":"10.1136\/bcr-2017-220188","article-title":"Pure red cell aplasia and myasthenia gravis: a patient having both autoimmune conditions in the absence of thymoma","author":"Aquilina","year":"2017","journal-title":"BMJ Case Rep."},{"key":"10.1016\/j.intimp.2024.113960_b1240","first-page":"3364","article-title":"Human parvovirus B19 nonstructural protein NS1 activates NLRP3 inflammasome signaling in adult\u2011onset Still's disease","volume":"17","author":"Chen","year":"2018","journal-title":"Mol Med Rep."},{"key":"10.1016\/j.intimp.2024.113960_b1245","doi-asserted-by":"crossref","first-page":"e293","DOI":"10.1097\/RHU.0000000000001433","article-title":"Parvovirus-Induced Adult-Onset Still Disease Presenting With Elevated Liver Transaminases","volume":"27","author":"Al-Humadi","year":"2021","journal-title":"J Clin Rheumatol."},{"key":"10.1016\/j.intimp.2024.113960_b1250","article-title":"Parvovirus Infection Triggering Still's Disease","volume":"9","author":"Altuzarra-Ranedo","year":"2022","journal-title":"Eur J Case Rep Intern Med."},{"key":"10.1016\/j.intimp.2024.113960_b1255","first-page":"207","article-title":"Parvovirus infection in early arthritis","volume":"34","author":"Mauermann","year":"2016","journal-title":"Clin Exp Rheumatol."},{"key":"10.1016\/j.intimp.2024.113960_b1260","doi-asserted-by":"crossref","first-page":"4296","DOI":"10.1002\/ehf2.13520","article-title":"Progressive chronic SARS-CoV-2-positive giant cell myoendocarditis with atrial standstill and sudden cardiac death","volume":"8","author":"Blagova","year":"2021","journal-title":"ESC Heart Fail."},{"key":"10.1016\/j.intimp.2024.113960_b1265","doi-asserted-by":"crossref","first-page":"158","DOI":"10.1177\/1093526619865641","article-title":"Parvovirus B19 Myocarditis: Looking Beyond the Heart","volume":"23","author":"Izquierdo-Blasco","year":"2020","journal-title":"Pediatr Dev Pathol."},{"key":"10.1016\/j.intimp.2024.113960_b1270","doi-asserted-by":"crossref","first-page":"836","DOI":"10.1007\/s00108-009-2559-8","article-title":"The heart in viral infections","volume":"51","author":"Pankuweit","year":"2010","journal-title":"Internist (berl)."},{"key":"10.1016\/j.intimp.2024.113960_b1275","doi-asserted-by":"crossref","first-page":"s39","DOI":"10.2741\/962","article-title":"Human viral cardiomyopathy","volume":"8","author":"Maisch","year":"2003","journal-title":"Front Biosci."}],"container-title":["International Immunopharmacology"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S1567576924024822?httpAccept=text\/xml","content-type":"text\/xml","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S1567576924024822?httpAccept=text\/plain","content-type":"text\/plain","content-version":"vor","intended-application":"text-mining"}],"deposited":{"date-parts":[[2025,2,20]],"date-time":"2025-02-20T23:26:02Z","timestamp":1740093962000},"score":1,"resource":{"primary":{"URL":"https:\/\/linkinghub.elsevier.com\/retrieve\/pii\/S1567576924024822"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2025,2]]},"references-count":255,"alternative-id":["S1567576924024822"],"URL":"https:\/\/doi.org\/10.1016\/j.intimp.2024.113960","relation":{},"ISSN":["1567-5769"],"issn-type":[{"value":"1567-5769","type":"print"}],"subject":[],"published":{"date-parts":[[2025,2]]},"assertion":[{"value":"Elsevier","name":"publisher","label":"This article is maintained by"},{"value":"Clinical implications of human Parvovirus B19 infection on autoimmunity and autoimmune diseases","name":"articletitle","label":"Article Title"},{"value":"International Immunopharmacology","name":"journaltitle","label":"Journal Title"},{"value":"https:\/\/doi.org\/10.1016\/j.intimp.2024.113960","name":"articlelink","label":"CrossRef DOI link to publisher maintained version"},{"value":"article","name":"content_type","label":"Content Type"},{"value":"\u00a9 2024 Elsevier B.V. All rights are reserved, including those for text and data mining, AI training, and similar technologies.","name":"copyright","label":"Copyright"}],"article-number":"113960"}}